益丰药房:益丰药房2024年年度报告(英文版)

Company code:603939 Company abbreviation: Yifeng Pharmacy
Yifeng Pharmacy Chain Co., Ltd.
2024Annual Report
This report is prepared in both Chinese and English and is published electronically. If there is any
inconsistency between the two versions, the Chinese version shall prevail.

Important Notes
I. The Board of Directors, Board of Supervisors, directors, supervisors and senior management
of the Company hereby guarantee that the contents are authentic, accurate, and complete,
without false records, misleading representations or material omissions in the Annual Report,
and shall take all the joint and several legal liabilities.
II. All the directors have attended the meeting of the Board of Directors.
III. Pan-China Certified Public Accountants has issued a standard unqualified audit report for
the Company.
IV. Gao Yi, the Company’s responsible person, Wang Yonghui, responsible person in charge of
accounting work, and Guan Changfu, the accounting firm’s responsible person (accounting
superintendent) hereby declare and warrant that the financial report in the Annual Report is
authentic, accurate, and complete.
V. The plan of profit distribution or the conversion of capital reserves into share capital for the
Reporting Period has been approved by the Board of Directors
Based on the audit conducted by Pan-China Certified Public Accountants (special general
partnership), as of December 31, 2024, the undistributed profits in the parent company’s financial
statements amounted to CN¥854,914,834.22.
In 2024, the Company achieved a net profit attributable to the parent company amounting to CN¥ 1,
528,576,669.36.After adding the undistributed profit from the beginning of 2024, which was CN¥ 4,774
,244,419.42, and deducting the statutory surplus reserve of CN¥ 127,737,417.19 extracted at the end of
the year, along with a dividend payout of CN¥ 505,289,898.50 for 2023, and a dividend payout of
303,114,161.25 for mid 2024, the profit available for distribution to shareholders totaled CN¥ 5,366,679,
611.84.
The Company proposes to distribute a cash dividend of CN¥0.40 (tax included) per share to all
shareholders. As of March 31, 2025, the Company’s total share capital stood at 1,212,416,794 shares,
resulting in a proposed total cash dividend distribution of CN¥484,966,717.60 (tax included). Should the
Company’s total share capital change between the disclosure date of this profit distribution plan and the
equity registration date for its implementation, due to factors such as convertible bond conversion or
repurchase and cancellation of shares granted under equity incentives, the Company intends to maintain
the per-share distribution ratio while adjusting the total distribution amount accordingly.Any subsequent
changes in total share capital will be announced separately with specific adjustment details. The profit
distribution plan above is subject to approval by the Company’s shareholders at the general meeting
before implementation.
VI. Risk statement on forward-looking statements
"√Applicable" "□ Not applicable"
The forward-looking statements such as future plans and development strategies in the Annual
Report do not constitute a substantive commitment of the Company to investors. Investors should
therefore make rational investment based on an awareness of risk factors.
VII. Are there cases of non-operational fund occupancy by the controlling shareholder and other
related parties
No
VIII. Have there been any breaches of established decision-making procedures in providing
guarantees to external parties
No
IX. Has there been a situation where more than half of the directors cannot guarantee that the
Annual Report disclosed by the Company is authentic, accurate, and complete
No
X. Significant risk warnings
During the Reporting Period, no significant risks had a substantial impact on the Company’s
production and operation activities. The Company has extensively elaborated on potential risks in this
report. For more details, please refer to Subsection "Potential Risks" under Section III “Management
Discussion and Analysis”.
XI. Others
"□Applicable""√ Not applicable"

Contents

Section I. Paraphrase......5
Section II. Company Profile and Main Financial Indicators......6
Section III. Management Discussion and Analysis......11
Section IV. Corporate Governance......45
Section V. Environmental and Social Responsibility......72
Section VI. Important matters......74
Section VII. Changes in Shares and Shareholders......115
Section VIII. Overview of Preferred Share......124
Section IX. Overview of Bonds......125
Section X. Financial Statements......128
Accounting statements with the signatures and seals of the Company’s responsible
person, the responsible person in charge of acc